CAPD in patients with autosomal dominant polycystic kidney disease

被引:6
|
作者
Hadimeri, H
Johansson, AC
Haraldsson, B
Nyberg, G [1 ]
机构
[1] Sahlgrenska Univ Sjukhuset, Transplant Unit, S-41345 Gothenburg, Sweden
[2] Sahlgrenska Univ Sjukhuset, Dept Nephrol, S-41345 Gothenburg, Sweden
来源
PERITONEAL DIALYSIS INTERNATIONAL | 1998年 / 18卷 / 04期
关键词
autosomal dominant PKD; dialysis efficacy; hernia; peritonitis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate whether there are specific complications to continuous ambulatory peritoneal dialysis (CAPD) in patients with autosomal dominant polycystic kidney disease (ADPKD) due to defects in various wall structures - causing hernia and diverticulitis - and to enlarged kidneys. Design:The clinical experience of CAPD in 26 patients with ADPKD, treated for 11 +/- 6 months, was studied in retrospect and compared with that of 26 contemporary controls. Medical records were reviewed with respect to survival in this treatment form and any complication. Peritoneal dialysis capacity (PDC), as measured in 21 ADPKD patients and 20 controls, was also evaluated. Setting: University Hospital. Results: Before initiation of CAPD, enlarged kidneys necessitated nephrectomy in 2 of 26 ADPKD patients; both cases were registered as preparation for transplantation, not for CARD. Survival in CAPD was similar in ADPKD patients and controls. Hernia was present in 4 ADPKD patients and 2 controls, and required transfer to hemodialysis in 1 patient from each group, temporarily. The incidence of peritonitis was I per 20 months in ADPKD patients versus 1 in 27 months in the controls, not significantly different. Peritonitis was caused by colonic bacteria in similar numbers. Residual renal function was 1.9 +/- 2.1 mL/min per 1.73 m(2) in ADPKD patients versus 1.9 +/- 1.4 mllmin per 1.73 m(2) in the controls. No difference was detected in any of the variables measured by PDC. Conclusion: There were no specific problems related to ADPKD.
引用
收藏
页码:429 / 432
页数:4
相关论文
共 50 条
  • [1] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [2] Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
    Walz, Gerd
    Budde, Klemens
    Mannaa, Marwan
    Nuernberger, Jens
    Wanner, Christoph
    Sommerer, Claudia
    Kunzendorf, Ulrich
    Banas, Bernhard
    Hoerl, Walter H.
    Obermueller, Nicholas
    Arns, Wolfgang
    Pavenstaedt, Hermann
    Gaedeke, Jens
    Buechert, Martin
    May, Christoph
    Gschaidmeier, Harald
    Kramer, Stefan
    Eckardt, Kai-Uwe
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09): : 830 - 840
  • [3] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283
  • [4] Autosomal dominant polycystic kidney disease
    Simms, Roslyn J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [5] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [6] Autosomal Dominant Polycystic Kidney Disease
    Zacharia, George Sarin
    Rajakumari, P. K.
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2013, 3 (04): : 194 - 195
  • [7] AUTOSOMAL DOMINANT POLYCYSTIC DISEASE OF THE KIDNEY
    FICK, G
    WEBER, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (30) : 1160 - 1164
  • [8] Autosomal dominant polycystic kidney disease
    Silverman, Jonathan
    Desai, Chaitanya
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (10): : 442 - 447
  • [9] Autosomal dominant polycystic kidney disease
    Ferrer, Elisa
    Bozzo, Jordi
    DRUGS OF THE FUTURE, 2006, 31 (07) : 611 - 615
  • [10] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Pljesa, Steva
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 340 - 347